Avian influenza A(H7N9) virus infection
References
Key articles
Centers for Disease Control and Prevention. Asian lineage avian influenza A (H7N9) virus. Dec 2018 [internet publication].Full text
Public Health England. Avian influenza: guidance, data and analysis. Mar 2019 [internet publication].Full text
World Health Organization. Avian influenza A(H7N9) virus: post-exposure antiviral chemoprophylaxis of close contacts of a patient with confirmed H7N9 virus infection and/or high risk poultry/environmental exposures. Jan 2014 [internet publication].Full text
Reference articles
1. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, et al; Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med. 2008 Jan 17;358(3):261-73.Full text Abstract
2. World Health Organization. Human infection with avian influenza A(H7N9) virus - China. Feb 2017 [internet publication].Full text
3. Yang JR, Liu MT. Human infection caused by an avian influenza A (H7N9) virus with a polybasic cleavage site in Taiwan, 2017. J Formos Med Assoc. 2017 Mar;116(3):210-2.Full text Abstract
4. Yu H, Cowling BJ, Feng L, et al. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet. 2013 Jul 13;382(9887):138-45.Full text Abstract
5. Chen Y, Liang W, Yang S, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet. 2013 Jun 1;381(9881):1916-25. Abstract
6. Yu X, Jin T, Cui Y, et al. Influenza H7N9 and H9N2 viruses: coexistence in poultry linked to human H7N9 infection and genome characteristics. J Virol. 2014 Mar;88(6):3423-31.Full text Abstract
7. Li Q, Zhou L, Zhou M, et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med. 2014 Feb 6;370(6):520-32.Full text Abstract
8. Qi X, Qian YH, Bao CJ, et al. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ. 2013 Aug 6;347:f4752.Full text Abstract
9. Xiang N, Iuliano AD, Zhang Y, et al. Comparison of the first three waves of avian influenza A(H7N9) virus circulation in the mainland of the People's Republic of China. BMC Infect Dis. 2016 Dec 5;16(1):734.Full text Abstract
10. Wang X, Wu P, Pei Y, et al. Assessment of human-to-human transmissibility of avian influenza A(H7N9) virus across 5 waves by analyzing clusters of case patients in mainland China, 2013-2017. Clin Infect Dis. 2019 Feb 1;68(4):623-31.Full text Abstract
11. Zhou L, Chen E, Bao C, et al. Clusters of human infection and human-to-human transmission of avian influenza A(H7N9) virus, 2013-2017. Emerg Infect Dis. 2018 Feb 17;24(2):397-400.Full text Abstract
12. Farooqui A, Liu W, Zeng T, et al. Probable hospital cluster of H7N9 influenza infection. N Engl J Med. 2016 Feb 11;374(6):596-8.Full text Abstract
13. Fang CF, Ma MJ, Zhan BD, et al. Nosocomial transmission of avian influenza A (H7N9) virus in China: epidemiological investigation. BMJ. 2015 Nov 19;351:h5765.Full text Abstract
14. Chen H, Liu S, Liu J, et al. Nosocomial co-transmission of avian influenza A(H7N9) and A(H1N1)pdm09 viruses between 2 patients with hematologic disorders. Emerg Infect Dis. 2016 Apr;22(4):598-607.Full text Abstract
15. Skowronski DM, Tweed SA, Petric M, et al. Human illness and isolation of low-pathogenicity avian influenza virus of the H7N3 subtype in British Columbia, Canada. J Infect Dis. 2006 Mar 15;193(6):899-900.Full text Abstract
16. Peiris M, Yuen KY, Leung CW, et al. Human infection with influenza H9N2. Lancet. 1999 Sep 11;354(9182):916-7. Abstract
17. Uyeki TM, Chong YH, Katz JM, et al. Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999. Emerg Infect Dis. 2002 Feb;8(2):154-9.Full text Abstract
18. Avian influenza A/(H7N2) outbreak in the United Kingdom. Euro Surveill. 2007 May 31;12(5):E070531.2. Abstract
19. Kurtz J, Manvell RJ, Banks J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet. 1996 Sep 28;348(9031):901-2. Abstract
20. World Health Organization. Avian influenza A(H7N9) virus. 2019 [internet publication].Full text
21. Tong XC, Weng SS, Xue F, et al. First human infection by a novel avian influenza A(H7N4) virus. J Infect. 2018 Jun 10;77(3):249-57. Abstract
22. Tweed SA, Skowronski DM, David ST, et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis. 2004 Dec;10(12):2196-9.Full text Abstract
23. Nguyen-Van-Tam JS, Nair P, Acheson P, et al. Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill. 2006 May 4;11(5):E060504.2. Abstract
24. International Society for Infectious Diseases. ProMED-mail. Avian influenza (59): China (SC) LPAI H5N6, human, first case, poultry. May 2014 [internet publication].Full text
25. Zhou L, Tan Y, Kang M, et al. Preliminary epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus, China, 2017. Emerg Infect Dis. 2017 Aug;23(8):1355-9.Full text Abstract
26. Liu D, Shi W, Shi Y, et al. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet. 2013 Jun 1;381(9881):1926-32. Abstract
27. Lam TT, Wang J, Shen Y, et al. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature. 2013 Oct 10;502(7470):241-4.Full text Abstract
28. Lu J, Wu J, Zeng X, et al. Continuing reassortment leads to the genetic diversity of influenza virus H7N9 in Guangdong, China. J Virol. 2014 Aug;88(15):8297-306.Full text Abstract
29. Pantin-Jackwood MJ, Miller PJ, Spackman E, et al. Role of poultry in the spread of novel H7N9 influenza virus in China. J Virol. 2014 May;88(10):5381-90.Full text Abstract
30. Iuliano AD, Jang Y, Jones J, et al. Increase in human infections with avian influenza A(H7N9) virus during the fifth epidemic - China, October 2016-February 2017. MMWR Morb Mortal Wkly Rep. 2017 Mar 10;66(9):254-5.Full text Abstract
31. Ocaña-Macchi M, Bel M, Guzylack-Piriou L, et al. Hemagglutinin-dependent tropism of H5N1 avian influenza virus for human endothelial cells. J Virol. 2009 Dec;83(24):12947-55.Full text Abstract
32. Baigent SJ, McCauley JW. Influenza type A in humans, mammals and birds: determinants of virus virulence, host-range and interspecies transmission. Bioessays. 2003 Jul;25(7):657-71. Abstract
33. Richard M, Herfst S, van den Brand JM, et al. Low virulence and lack of airborne transmission of the Dutch highly pathogenic avian influenza virus H5N8 in ferrets. PLoS One. 2015 Jun 19;10(6):e0129827.Full text Abstract
34. Richard M, Schrauwen EJ, de Graaf M, et al. Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature. 2013 Sep 26;501(7468):560-3.Full text Abstract
35. Zhou J, Wang D, Gao R, et al. Biological features of novel avian influenza A (H7N9) virus. Nature. 2013 Jul 25;499(7459):500-3. Abstract
36. Hay AJ, Hayden FG. Oseltamivir resistance during treatment of H7N9 infection. Lancet. 2013 Jun 29;381(9885):2230-2. Abstract
37. Hu Y, Lu S, Song Z, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet. 2013 Jun 29;381(9885):2273-9. Abstract
38. Liu X, Li T, Zheng Y, et al. Poor responses to oseltamivir treatment in a patient with influenza A (H7N9) virus infection. Emerg Microbes Infect. 2013 May;2(5):e27.Full text Abstract
39. Marjuki H, Mishin VP, Chesnokov AP, et al. Neuraminidase mutations conferring resistance to oseltamivir in influenza A(H7N9) viruses. J Virol. 2015 May;89(10):5419-26.Full text Abstract
40. Marjuki H, Mishin VP, Chesnokov AP, et al. Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. J Infect Dis. 2015 Jan 15;211(2):249-57.Full text Abstract
41. Gao HN, Yao HP, Liang WF, et al. Viral genome and antiviral drug sensitivity analysis of two patients from a family cluster caused by the influenza A(H7N9) virus in Zhejiang, China, 2013. Int J Infect Dis. 2014 Dec;29:254-8.Full text Abstract
42. European Centre for Disease Prevention and Control. Influenza A(H7N9) virus in China: implications for public health. Seventh update. Jul 2017 [internet publication].Full text
43. Gao R, Cao B, Hu Y, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013 May 16;368(20):1888-97.Full text Abstract
44. Tang J, Zhang J, Zhou J, et al. Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts. Virol J. 2019 Jul 2;16(1):87.Full text Abstract
45. Olson SH, Gilbert M, Cheng MC, et al. Historical prevalence and distribution of avian influenza virus A(H7N9) among wild birds. Emerg Infect Dis. 2013 Dec;19(12):2031-3.Full text Abstract
46. Ip DK, Liao Q, Wu P, et al. Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series. BMJ. 2013 Jun 24;346:f3693.Full text Abstract
47. World Health Organization. Avian influenza weekly update number 713: human infection with avian influenza A(H7N9) virus in China. Nov 2019 [internet publication].Full text
48. Centers for Disease Control and Prevention. Asian lineage avian influenza A (H7N9) virus. Dec 2018 [internet publication].Full text
49. World Health Organization. Frequently asked questions on human infection caused by the avian influenza A(H7N9) virus. Feb 2014 [internet publication].Full text
50. Uyeki TM, Katz JM, Jernigan DB. Novel influenza A viruses and pandemic threats. Lancet. 2017 Jun 3;389(10085):2172-4. Abstract
51. Wang X, Jiang H, Wu P, et al. Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series. Lancet Infect Dis. 2017 Aug;17(8):822-32. Abstract
52. Kile JC, Ren R, Liu L, et al. Update: increase in human infections with novel Asian lineage avian influenza A(H7N9) viruses during the fifth epidemic - China, October 1, 2016-August 7, 2017. MMWR Morb Mortal Wkly Rep. 2017 Sep 8;66(35):928-32.Full text Abstract
53. Food and Agriculture Organization of the United Nations. H7N9 situation update. Nov 2019 [internet publication].Full text
54. Yuan J, Lau EH, Li K, et al. Effect of live poultry market closure on avian influenza A(H7N9) virus activity in Guangzhou, China, 2014. Emerg Infect Dis. 2015 Oct;21(10):1784-93.Full text Abstract
55. Yu H, Wu JT, Cowling BJ, et al. Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study. Lancet. 2014 Feb 8;383(9916):541-8.Full text Abstract
56. Li Y, Wang Y, Shen C, et al. Closure of live bird markets leads to the spread of H7N9 influenza in China. PLoS One. 2018 Dec 12;13(12):e0208884.Full text Abstract
57. Wu J, Ke C, Lau EH, et al. Influenza H5/H7 virus vaccination in poultry and reduction of zoonotic infections, Guangdong Province, China, 2017-18. Emerg Infect Dis. 2019 Jan 17;25(1):116-8.Full text Abstract
58. Cheng W, Chong KC, Lau SY, et al. Comparison of avian influenza virus contamination in the environment before and after massive poultry H5/H7 vaccination in Zhejiang Province, China. Open Forum Infect Dis. 2019 Apr 24;6(6):ofz197.Full text Abstract
59. Chang SY, Lin PH, Tsai JC, et al. The first case of H7N9 influenza in Taiwan. Lancet. 2013 May 11;381(9878):1621. Abstract
60. Ho PL, Sin WC, Chan JF, et al. Severe influenza A H7N9 pneumonia with rapid virological response to intravenous zanamivir. Eur Respir J. 2014 Aug;44(2):535-7.Full text Abstract
61. William T, Thevarajah B, Lee SF, et al. Avian influenza (H7N9) virus infection in Chinese tourist in Malaysia, 2014. Emerg Infect Dis. 2015 Jan;21(1):142-5.Full text Abstract
62. Skowronski DM, Chambers C, Gustafson R, et al. Avian influenza A(H7N9) virus infection in 2 travelers returning from China to Canada, January 2015. Emerg Infect Dis. 2016 Jan;22(1):71-4.Full text Abstract
63. European Centre for Disease Prevention and Control. Rapid risk assessment: human infection with avian influenza A viruses, China. Feb 2014 [internet publication].Full text
64. Wang C, Yu H, Horby PW, et al. Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clin Infect Dis. 2014 Apr;58(8):1095-103.Full text Abstract
65. Xiang N, Li X, Ren R, et al. Assessing change in avian influenza A(H7N9) virus infections during the fourth epidemic - China, September 2015-August 2016. MMWR Morb Mortal Wkly Rep. 2016 Dec 16;65(49):1390-4.Full text Abstract
66. Xu L, Bao L, Deng W, et al. Rapid adaptation of avian H7N9 virus in pigs. Virology. 2014 Feb 14;452-453:231-6.Full text Abstract
67. Zhou P, Hong M, Merrill MM, et al. Serological report of influenza A (H7N9) infections among pigs in Southern China. BMC Vet Res. 2014 Sep 2;10:203.Full text Abstract
68. Yum J, Park EH, Ku KB, et al. Low infectivity of a novel avian-origin H7N9 influenza virus in pigs. Arch Virol. 2014 Jun 7;159(10):2745-9. Abstract
69. Wang C, Wang J, Su W, et al. Relationship between domestic and wild birds in live poultry market and a novel human H7N9 virus in China. J Infect Dis. 2014 Jan 1;209(1):34-7.Full text Abstract
70. Jones JC, Sonnberg S, Koçer ZA, et al. Possible role of songbirds and parakeets in transmission of influenza A(H7N9) virus to humans. Emerg Infect Dis. 2014 Mar;20(3):380-5.Full text Abstract
71. Zhao B, Zhang X, Zhu W, et al. Novel avian influenza A(H7N9) virus in tree sparrow, Shanghai, China, 2013. Emerg Infect Dis. 2014 May;20(5):850-3.Full text Abstract
72. Kang M, Lau EHY, Guan W, et al. Epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus in Guangdong, 2016 to 2017. Euro Surveill. 2017 Jul 6;22(27):30568.Full text Abstract
73. Lee SS, Wong NS, Leung CC. Exposure to avian influenza H7N9 in farms and wet markets. Lancet. 2013 May 25;381(9880):1815. Abstract
74. Yang S, Chen Y, Cui D, et al. Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study. J Infect Dis. 2014 Jan 15;209(2):265-9.Full text Abstract
75. Quan C, Wang Q, Zhang J, et al. Avian influenza A viruses among occupationally exposed populations, China, 2014-2016. Emerg Infect Dis. 2019 Dec;25(12):2215-2225. Abstract
76. Yang P, Ma C, Cui S, et al. Avian influenza A(H7N9) and (H5N1) infections among poultry and swine workers and the general population in Beijing, China, 2013-2015. Sci Rep. 2016 Sep 27;6:33877. Abstract
77. Ma MJ, Zhao T, Chen SH, et al. Avian influenza A virus infection among workers at live poultry markets, China, 2013-2016. Emerg Infect Dis. 2018 Jul;24(7):1246-1256. Abstract
78. Bai T, Zhou J, Shu Y. Serologic study for influenza A (H7N9) among high-risk groups in China. N Engl J Med. 2013 Jun 13;368(24):2339-40.Full text Abstract
79. World Health Organization. WHO risk assessment: human infections with avian influenza A(H7N9) virus. Feb 2014 [internet publication].Full text
80. Pan H, Zhang X, Hu J, et al. A case report of avian influenza H7N9 killing a young doctor in Shanghai, China. BMC Infect Dis. 2015 Jun 23;15:237.Full text Abstract
81. World Health Organization. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010. Wkly Epidemiol Rec. 2010 Mar 12;85(11):100-7. Abstract
82. Butt KM, Smith GJ, Chen H, et al. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol. 2005 Nov;43(11):5760-7.Full text Abstract
83. Bos ME, Te Beest DE, van Boven M, et al. High probability of avian influenza virus (H7N7) transmission from poultry to humans active in disease control on infected farms. J Infect Dis. 2010 May 1;201(9):1390-6.Full text Abstract
84. Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet. 2004 Feb 21;363(9409):587-93. Abstract
85. Chow EJ, Davis CT, Abd Elal AI, et al. Update: influenza activity - United States and worldwide, May 20-October 13, 2018. MMWR Morb Mortal Wkly Rep. 2018 Oct 26;67(42):1178-85.Full text Abstract
86. Arzey GG, Kirkland PD, Arzey KE, et al. Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia. Emerg Infect Dis. 2012 May;18(5):814-6.Full text Abstract
87. Wei SH, Yang JR, Wu HS, et al. Human infection with avian influenza A H6N1 virus: an epidemiological analysis. Lancet Respir Med. 2013 Dec;1(10):771-8. Abstract
88. Public Health England. Avian influenza: guidance, data and analysis. Mar 2019 [internet publication].Full text
89. Tong S, Zhu X, Li Y, et al. New world bats harbor diverse influenza A viruses. PLoS Pathog. 2013;9(10):e1003657.Full text Abstract
90. Wu Y, Wu Y, Tefsen B, et al. Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol. 2014 Apr;22(4):183-91. Abstract
91. Yamada S, Suzuki Y, Suzuki T, et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature. 2006 Nov 16;444(7117):378-82. Abstract
92. Peng J, Yang H, Jiang H, et al. The origin of novel avian influenza A (H7N9) and mutation dynamics for its human-to-human transmissible capacity. PLoS One. 2014 Mar 26;9(3):e93094.Full text Abstract
93. Zhu W, Zhou J, Li Z, et al. Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017. Euro Surveill. 2017 May 11;22(19):30533.Full text Abstract
94. Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009 Jun 18;360(25):2605-15.Full text Abstract
95. Horimoto T, Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol. 2005 Aug;3(8):591-600. Abstract
96. van Riel D, Leijten LM, de Graaf M, et al. Novel avian-origin influenza A (H7N9) virus attaches to epithelium in both upper and lower respiratory tract of humans. Am J Pathol. 2013 Oct;183(4):1137-43.Full text Abstract
97. Chan MC, Chan RW, Chan LL, et al. Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract. Lancet Respir Med. 2013 Sep;1(7):534-42. Abstract
98. Siegers JY, Short KR, Leijten LM, et al. Novel avian-origin influenza A (H7N9) virus attachment to the respiratory tract of five animal models. J Virol. 2014 Apr;88(8):4595-9.Full text Abstract
99. Watanabe T, Kiso M, Fukuyama S, et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature. 2013 Sep 26;501(7468):551-5.Full text Abstract
100. Zhu H, Wang D, Kelvin DJ, et al. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science. 2013 Jul 12;341(6142):183-6. Abstract
101. Mok CK, Lee HH, Chan MC, et al. Pathogenicity of the novel A/H7N9 influenza virus in mice. MBio. 2013 Jul 2;4(4):e00362-13.Full text Abstract
102. Chi Y, Zhu Y, Wen T, et al. Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China. J Infect Dis. 2013 Dec 15;208(12):1962-7.Full text Abstract
103. Wang Z, Zhang A, Wan Y, et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):769-74.Full text Abstract
104. Everitt AR, Clare S, Pertel T, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature. 2012 Mar 25;484(7395):519-23.Full text Abstract
105. Zhang YH, Zhao Y, Li N, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun. 2013;4:1418.Full text Abstract
106. Lee N, Cao B, Ke C, et al. IFITM3, TLR3, and CD55 genes SNPs and cumulative genetic risks for severe outcomes in Chinese patients with H7N9 / H1N1pdm09 influenza. J Infect Dis. 2017 Jul 1;216(1):97-104. Abstract
107. Yu L, Wang Z, Chen Y, et al. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. Clin Infect Dis. 2013 Nov;57(10):1449-57.Full text Abstract
108. Lu S, Li T, Xi X, et al. Prognosis of 18 H7N9 avian influenza patients in Shanghai. PLoS One. 2014 Apr 2;9(4):e88728.Full text Abstract
109. Ai J, Huang Y, Xu K, et al. Case-control study of risk factors for human infection with influenza A(H7N9) virus in Jiangsu Province, China, 2013. Euro Surveill. 2013 Jun 27;18(26):20510. Abstract
110. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005 Sep 29;353(13):1374-85.Full text Abstract
111. World Health Organization. Laboratory biorisk management for laboratories handling human specimens suspected or confirmed to contain avian influenza A(H7N9) virus causing human disease: interim recommendations. May 2013 [internet publication].Full text
112. Ortiz JR, Katz MA, Mahmoud MN, et al. Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006. J Infect Dis. 2007 Dec 1;196(11):1685-91.Full text Abstract
113. Ma MJ, Ma GY, Yang XX, et al. Avian Influenza A(H7N9) virus antibodies in close contacts of infected persons, China, 2013-2014. Emerg Infect Dis. 2015 Apr;21(4):709-11.Full text Abstract
114. Lv H, Han J, Zhang P, et al. Mild illness in avian influenza A(H7N9) virus-infected poultry worker, Huzhou, China, April 2013. Emerg Infect Dis. 2013 Nov;19(11):1885-8.Full text Abstract
115. Chen Z, Liu H, Lu J, et al. Asymptomatic, mild, and severe influenza A(H7N9) virus infection in humans, Guangzhou, China. Emerg Infect Dis. 2014 Sep;20(9):1535-40.Full text Abstract
116. Gao HN, Lu HZ, Cao B, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013 Jun 13;368(24):2277-85.Full text Abstract
117. Virlogeux V, Li M, Tsang TK, et al. Estimating the distribution of the incubation periods of human avian influenza A(H7N9) virus infections. Am J Epidemiol. 2015 Oct 15;182(8):723-9.Full text Abstract
118. Zhou L, Li Q, Uyeki TM. Estimated incubation period and serial interval for human-to-human influenza A(H7N9) virus transmission. Emerg Infect Dis. 2019 Oct 17;25(10):1982-3.Full text Abstract
119. Ke C, Mok CKP, Zhu W, et al. Human infection with highly pathogenic avian influenza A(H7N9) virus, China. Emerg Infect Dis. 2017 Jul;23(8):1332-40.Full text Abstract
120. Yang Y, Wong G, Yang L, et al. Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: clinical and virological findings. J Infect. 2019 Jan 18;78(3):241-8. Abstract
121. Centers for Disease Control and Prevention. Interim guidance for infection control within healthcare settings when caring for confirmed cases, probable cases, and cases under investigation for infection with novel influenza A viruses associated with severe disease. Jan 2014 [internet publication].Full text
122. Public Health England. Laboratory investigations for avian influenza A(H7) and A(H5) human infections in England. 2016 [internet publication].Full text
123. Baas C, Barr IG, Fouchier RA, et al. A comparison of rapid point-of-care tests for the detection of avian influenza A(H7N9) virus, 2013. Euro Surveill. 2013 May 23;18(21):20487.Full text Abstract
124. Centers for Disease Control and Prevention. Interim guidance for specimen collection, processing, and testing for patients who may be infected with avian influenza A (H7N9) virus. Jan 2016 [internet publication].Full text
125. Chan KH, To KK, Chan JF, et al. Analytical sensitivity of seven point-of-care influenza virus detection tests and two molecular tests for detection of avian origin H7N9 and swine origin H3N2 variant influenza A viruses. J Clin Microbiol. 2013 Sep;51(9):3160-1.Full text Abstract
126. Feng F, Jiang Y, Yuan M, et al. Association of radiologic findings with mortality in patients with avian influenza H7N9 pneumonia. PLoS One. 2014 Apr 4;9(4):e93885.Full text Abstract
127. World Health Organization. Real-time RT-PCR protocol for the detection of avian influenza A(H7N9) virus. May 2013 [internet publication].Full text
128. Torres A, Lee N, Cilloniz C, et al. Laboratory diagnosis of pneumonia in the molecular age. Eur Respir J. 2016 Dec;48(6):1764-78.Full text Abstract
129. World Health Organization. WHO information for the molecular detection of influenza viruses. Jul 2017 [internet publication].Full text
130. World Health Organization. WHO reference laboratories for diagnosis of influenza A/H5 infection. Jun 2019 [internet publication].Full text
131. Chen Y, Wang D, Zheng S, et al. Rapid diagnostic tests for identifying avian influenza A(H7N9) virus in clinical samples. Emerg Infect Dis. 2015 Jan;21(1):87-90.Full text Abstract
132. World Health Organization. Laboratory procedures: serological detection of avian influenza A(H7N9) infections by microneutralization assay. May 2013 [internet publication].Full text
133. World Health Organization. Laboratory procedures: serological detection of avian influenza A(H7N9) virus infections by modified horse red blood cells haemagglutination-inhibition assay. Dec 2013 [internet publication].Full text
134. Zhu Y, Qi X, Cui L, et al. Human co-infection with novel avian influenza A H7N9 and influenza A H3N2 viruses in Jiangsu province, China. Lancet. 2013 Jun 15;381(9883):2134. Abstract
135. Zhang W, Zhu D, Tian D, et al. Co-infection with avian (H7N9) and pandemic (H1N1) 2009 influenza viruses, China. Emerg Infect Dis. 2015 Apr;21(4):715-8.Full text Abstract
136. American Academy of Pediatrics. Respiratory syncytial virus. In: Pickering LK, ed. Red book: 2006 report of the Committee on Infectious Diseases, 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:561.
137. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). Mar 2019 [internet publication].Full text
138. Centers for Disease Control and Prevention. Middle East respiratory syndrome (MERS). Aug 2019 [internet publication].Full text
139. Public Health England. MERS-CoV: clinical management and guidance. Sep 2018 [internet publication].Full text
140. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV): WHO MERS global summary and assessment of risk. Jul 2019 [internet publication].Full text
141. World Health Organization. WHO rapid advice guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus. May 2006 [internet publication].Full text
142. World Health Organization. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. Feb 2010 [internet publication].Full text
143. World Health Organization. Avian influenza A(H7N9) virus: post-exposure antiviral chemoprophylaxis of close contacts of a patient with confirmed H7N9 virus infection and/or high risk poultry/environmental exposures. Jan 2014 [internet publication].Full text
144. Centers for Disease Control and Prevention. Interim guidance on follow-up of close contacts of persons infected with novel influenza A viruses associated with severe human disease and on the use of antiviral medications for chemoprophylaxis. Mar 2017 [internet publication].Full text
145. Public Health England. Investigation and initial clinical management of possible human cases of avian influenza viruses that have been associated with severe human disease. Jun 2019 [internet publication].Full text
146. Centers for Disease Control and Prevention. Interim guidance on the use of antiviral medications for treatment of human infections with novel influenza A viruses associated with severe human disease. Apr 2015 [internet publication].Full text
147. Arabi Y, Gomersall CD, Ahmed QA, et al. The critically ill avian influenza A (H5N1) patient. Crit Care Med. 2007 May;35(5):1397-403. Abstract
148. World Health Organization. Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. Nov 2009 [internet publication].Full text
149. Zheng S, Tang L, Gao H, et al. Benefit of early initiation of neuraminidase inhibitor treatment to hospitalized patients with avian influenza A(H7N9) virus. Clin Infect Dis. 2018 Mar 19;66(7):1054-60.Full text Abstract
150. Zheng S, Zou Q, Wang X, et al. Factors associated with fatality due to avian influenza A(H7N9) infection in China. Clin Infect Dis. 2019;ciz779. Abstract
151. Wang Y, Guo Q, Yan Z, et al; CAP-China Network. Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection. J Infect Dis. 2018 May 5;217(11):1708-17.Full text Abstract
152. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006 Oct;12(10):1203-7.Full text Abstract
153. Kandeel A, Manoncourt S, Abd el Kareem E, et al. Zoonotic transmission of avian influenza virus (H5N1), Egypt, 2006-2009. Emerg Infect Dis. 2010 Jul;16(7):1101-7.Full text Abstract
154. Kandun IN, Tresnaningsih E, Purba WH, et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet. 2008 Aug 30;372(9640):744-9. Abstract
155. Adisasmito W, Chan PK, Lee N, et al. Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry. J Infect Dis. 2010 Oct 15;202(8):1154-60.Full text Abstract
156. Chan PK, Lee N, Zaman M, et al. Determinants of antiviral effectiveness in influenza virus A subtype H5N1. J Infect Dis. 2012 Nov;206(9):1359-66.Full text Abstract
157. Oner AF, Dogan N, Gasimov V, et al. H5N1 avian influenza in children. Clin Infect Dis. 2012 Jul;55(1):26-32.Full text Abstract
158. Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014 May;2(5):395-404. Abstract
159. Lee N, Leo YS, Cao B, et al. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. Eur Respir J. 2015 Jun;45(6):1642-52.Full text Abstract
160. Li TC, Chan MC, Lee N. Clinical implications of antiviral resistance in influenza. Viruses. 2015 Sep 14;7(9):4929-44.Full text Abstract
161. Duval X, van der Werf S, Blanchon T, et al; Bivir Study Group. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med. 2010 Nov 2;7(11):e1000362.Full text Abstract
162. Centers for Disease Control and Prevention. Interim guidance for infection control within healthcare settings when caring for confirmed cases, probable cases, and cases under investigation for infection with novel influenza A viruses associated with severe disease. Jan 2016 [internet publication].Full text
163. World Health Organization. Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care. Apr 2014 [internet publication].Full text
164. Cao B, Gao H, Zhou B, et al. Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia. Crit Care Med. 2016 Jun;44(6):e318-28. Abstract
165. Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis. 2009 Aug 15;200(4):492-500.Full text Abstract
166. Han K, Ma H, An X, et al. Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection. Clin Infect Dis. 2011 Aug;53(4):326-33.Full text Abstract
167. Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2013-2014. Pediatrics. 2013 Oct;132(4):e1089-104.Full text Abstract
168. Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. Nov 2019 [internet publication].Full text
169. Kayali G, Webby RJ, Ducatez MF, et al. The epidemiological and molecular aspects of influenza H5N1 viruses at the human-animal interface in Egypt. PLoS One. 2011 Mar 21;6(3):e17730.Full text Abstract
170. Zarychanski R, Stuart TL, Kumar A, et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ. 2010 Feb 23;182(3):257-64.Full text Abstract
171. Fiebig L, Soyka J, Buda S, et al. Avian influenza A(H5N1) in humans: new insights from a line list of World Health Organization confirmed cases, September 2006 to August 2010. Euro Surveill. 2011 Aug 11;16(32):19941. Abstract
172. Lee N, Hui DS, Zuo Z, et al. A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections. Clin Infect Dis. 2013 Dec;57(11):1511-9.Full text Abstract
173. Ariano RE, Sitar DS, Zelenitsky SA, et al. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ. 2010 Mar 9;182(4):357-63.Full text Abstract
174. Taylor WR, Thinh BN, Anh GT, et al. Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza. PLoS One. 2008;3(10):e3410.Full text Abstract
175. Taniguchi K, Ando Y, Nobori H, et al. Inhibition of avian-origin influenza A(H7N9) virus by the novel cap-dependent endonuclease inhibitor baloxavir marboxil. Sci Rep. 2019 Mar 5;9(1):3466.Full text Abstract
176. Hayden FG, Sugaya N, Hirotsu N, et al; Baloxavir Marboxil Investigators Group. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018 Sep 6;379(10):913-23.Full text Abstract
177. Uehara T, Hayden FG, Kawaguchi K, et al. Treatment-emergent influenza variant viruses with reduced baloxavir susceptibility: impact on clinical and virologic outcomes in uncomplicated influenza. J Infect Dis. 2019 Jul 16 [Epub ahead of print].Full text Abstract
178. Omoto S, Speranzini V, Hashimoto T, et al. Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil. Sci Rep. 2018 Jun 25;8(1):9633.Full text Abstract
179. Takashita E, Kawakami C, Morita H, et al; Influenza Virus Surveillance Group Of Japan. Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Euro Surveill. 2019 Jan;24(3):ES.2019.24.3.1800698.Full text Abstract
180. Wu XX, Gao HN, Wu HB, et al. Successful treatment of avian-origin influenza A (H7N9) infection using convalescent plasma. Int J Infect Dis. 2015 Dec;41:3-5.Full text Abstract
181. Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med. 2007 Oct 4;357(14):1450-1.Full text Abstract
182. Yu H, Gao Z, Feng Z, et al. Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One. 2008 Aug 21;3(8):e2985.Full text Abstract
183. ClinicalTrials.gov. Development of immune globulin treatment for avian flu. Apr 2016 [internet publication].Full text
184. Hung IF, To KK, Lee CK, et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis. 2011 Feb 15;52(4):447-56.Full text Abstract
185. Kohno S, Yen MY, Cheong HJ, et al; S-021812 Clinical Study Group. Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection. Antimicrob Agents Chemother. 2011 Nov;55(11):5267-76.Full text Abstract
186. Kohno S, Kida H, Mizuguchi M, et al; S-021812 Clinical Study Group. Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother. 2011 Jun;55(6):2803-12.Full text Abstract
187. Lee N, Chan PK, Tam WW, et al. Virological response to peramivir treatment in adults hospitalised for influenza-associated lower respiratory tract infections. Int J Antimicrob Agents. 2016 Aug;48(2):215-9. Abstract
188. Marty FM, Vidal-Puigserver J, Clark C, et al. Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial. Lancet Respir Med. 2017 Feb;5(2):135-46. Abstract
189. Ikematsu H, Kawai N. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza. Expert Rev Anti Infect Ther. 2011 Oct;9(10):851-7. Abstract
190. Furuta Y, Gowen BB, Takahashi K, et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res. 2013 Nov;100(2):446-54.Full text Abstract
191. Ilyushina NA, Hay A, Yilmaz N, et al. Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice. Antimicrob Agents Chemother. 2008 Nov;52(11):3889-97.Full text Abstract
192. Muller MP, Dresser L, Raboud J, et al. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome. Pharmacotherapy. 2007 Apr;27(4):494-503. Abstract
193. Centers for Disease Control and Prevention. Ventilator-associated pneumonia (VAP). Nov 2010 [internet publication].Full text
194. Lee CM, Hudson LD. Long-term outcomes after ARDS. Semin Respir Crit Care Med. 2001 Jun;22(3):327-36. Abstract
Use of this content is subject to our disclaimer